Therapies

Aims & Scope

Therapies is a peer-reviewed journal devoted to Clinical Pharmacology, Therapeutics, Pharmacokinetics, Pharmacovigilance, Addictovigilance, Social Pharmacology, Pharmacoepidemiology, Pharmacoeconomics and Evidence-Based-Medicine.

Thérapie publishes in French or in English original articles, general reviews, letters to the editor reporting original findings, correspondence relating to articles or letters published in the Journal, short articles, editorials on up-to-date topics, Pharmacovigilance or Addictovigilance reports that follow the French "guidelines" concerning good practice in pharmacovigilance publications.

The journal also publishes thematic issues on topical subject.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	1.8
2024	2.20

SJR (SCImago Journal Rank)

Year	Value
2024	0.432

Quartile

Year	Value
2024	Q3

h-index

Year	Value
2024	44

Journal Rank

Year	Value
2024	13079

Journal Citation Indicator

Year	Value
2024	382

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Case–non-case studies: Principle, methods, bias and interpretation

  Citation: 251

  Authors: Jean-Luc

• Serotonin 5-HT2C Receptors as a Target for the Treatment of Depressive and Anxious States: Focus on Novel Therapeutic Strategies

  Citation: 232

  Authors: Mark John

• Causality assessment in pharmacovigilance: The French method and its successive updates

  Citation: 205

  Authors: Ghada, Hélène, Françoise, Bernard

• Pharmacovigilance – The next chapter

  Citation: 143

  Authors: Nicholas, Driss, Patrick, Cécile

• Uses of pharmacovigilance databases: An overview

  Citation: 135

  Authors: Kévin, Bénédicte, Christian, Joe-Elie

• “Off-label” use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers

  Citation: 96

  Authors: Alexandre, Serena, Audrey, Delphine, Nadège, Aurélie, Laurent, Fanny, Milou-Daniel

• French administrative health care database (SNDS): The value of its enrichment

  Citation: 88

  Authors: Lucie-Marie, Catherine, Frédéric, Emmanuel, Sandrine, Alain, Erwan, André, Emmanuel

• Non-steroidal anti-inflammatory drugs, pharmacology, and COVID-19 infection

  Citation: 82

  Authors: Joëlle, Thomas, Annie-Pierre

• Updating the French Method for the Causality Assessment of Adverse Drug Reactions

  Citation: 81

  Authors: Yannick, Irène, Jean-Paul, Marie, Claire, Françoise, Dominique, Carmine, Catherine, Hélène, Marie-Blanche

• Long-term use of proton pump inhibitors as a risk factor for various adverse manifestations

  Citation: 79

  Authors: Arun

---